Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia

被引:0
作者
Keun-Ryung Bae
Hyun-Jung Shim
Deebika Balu
Sang Ryong Kim
Seong-Woon Yu
机构
[1] Daegu Gyeongbuk Institute of Science and Technology (DGIST),Department of Brain Science
[2] Michigan State University,Department of Neurology and Ophthalmology
[3] University of Illinois,Department of Biological Sciences
[4] Kyungpook National University,School of Life Sciences & Biotechnology, Institute of Life Science and Biotechnology, Brain Science and Engineering Institute
来源
Journal of Neuroimmune Pharmacology | 2014年 / 9卷
关键词
Translocator protein 18 kDa; Microglia; Neuroinflammation; NF-κB; Neurodegeneration;
D O I
暂无
中图分类号
学科分类号
摘要
Translocator protein 18 kDa (TSPO) is a mitochondrial outer membrane protein. Although TSPO expression is up-regulated during neuroinflammation, the role of TSPO and its signaling mechanisms in regulation of neuroinflammation remains to be elucidated at the molecular level. Here we demonstrate that TSPO is a negative regulator of neuroinflammation in microglia. Over-expression of TSPO decreased production of pro-inflammatory cytokines upon lipopolysaccharide treatment while TSPO knock-down had the opposite effect. Anti-inflammatory activity of TSPO is also supported by increased expression of alternatively activated M2 stage-related genes. These data suggest that up-regulation of TSPO level during neuroinflammation may be an adaptive response mechanism. We also provide the evidence that the repressive activity of TSPO is at least partially mediated by the attenuation of NF-κB activation. Neurodegenerative diseases are characterized by loss of specific subsets of neurons at the particular anatomical regions of the central nervous system. Cause of neuronal death is still largely unknown, but it is becoming clear that neuroinflammation plays a significant role in the pathophysiology of neurodegenerative diseases. Understanding the mechanisms underlying the inhibitory effects of TSPO on neuroinflammation can contribute to the therapeutic design for neurodegenerative diseases.
引用
收藏
页码:424 / 437
页数:13
相关论文
共 332 条
[11]  
Bocchini V(2003)In vivo and in vitro peripheral-type benzodiazepine receptor polymerization: functional significance in drug ligand and cholesterol binding Biochemistry 42 4506-4519
[12]  
Mazzolla R(2008)Microglia, amyloid, and cognition in Alzheimer’s disease: an [ Neurobiol Dis 32 412-419
[13]  
Barluzzi R(2011)C] (R) PK11195-PET and [ J Neurosci 31 1081-1092
[14]  
Blasi E(1993)C] PIB-PET study Glia 7 102-110
[15]  
Sick P(2010)HMGB1 acts on microglia Mac1 to mediate chronic neuroinflammation that drives progressive neurodegeneration Cell 140 918-934
[16]  
Kettenmann H(2008)Reactive glia as rivals in regulating neuronal survival J Steroid Biochem Mol Biol 109 96-107
[17]  
Buck JR(2011)Mechanisms underlying inflammation in neurodegeneration Mol Ther 19 46-52
[18]  
McKinley ET(2002)Brain microglia express steroid-converting enzymes in the mouse J Neurochem 83 1226-1234
[19]  
Hight MR(2013)Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson’s disease Exp Neurobiol 22 59-67
[20]  
Fu A(2005)Effects on free radical generation by ligands of the peripheral benzodiazepine receptor in cultured neural cells Apoptosis 10 91-104